The USFDA has approved Teflaro (ceftaroline fosamil), an injectable antibiotic for the treatment in adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
The USFDA has approved the cancer drug Afinitor (everolimus) to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.
(Source: http://www.fda.gov/)
Showing posts with label ceftaroline. Show all posts
Showing posts with label ceftaroline. Show all posts
Tuesday, November 2, 2010
Subscribe to:
Posts (Atom)